Current status and advances in management of early breast cancer

International Journal of Surgery

Volumn 8, Issue 3, 2010, Pages 199-202

  Keshtgar, M ^a   Davidson, T ^a   Pigott, K ^a   Falzon, M ^b   Jones, A ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

Advances; Breast cancer; Chemotherapy; Diagnosis; Histopathology; Hormonal treatment; Radiotherapy; Surgery

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

BREAST CANCER; BREAST CONSERVING SURGERY; BREAST RECONSTRUCTION; BREAST SURGERY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; DIGITAL MAMMOGRAPHY; EARLY CANCER; FEMALE; HIGH RISK PATIENT; HISTOPATHOLOGY; HORMONAL THERAPY; HUMAN; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; MASTECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT COUNSELING; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; REVIEW; SENTINEL LYMPH NODE BIOPSY;

BREAST NEOPLASMS; FEMALE; HUMANS;

EID: 77950593572     PISSN: 17439191     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijsu.2010.02.004     Document Type: Review

References (32)

1. Office for national statistics mortality statistics: cause. England and Wales 2007London TSO; 2009.
2. Northern Ireland Cancer Registry, 2009Cancer Mortality in Northern Ireland, 2007.
3. ISD Online, 2009 Cancer mortality in Scotland; 2007.
4. Gotzsche P.C., Hartling O.J., Nielsen M., Brodersen J., and Jorgensen K.J. Breast screening: the facts - or maybe not. BMJ 338 (2009) b86
5. Davidson T.I., Mumtaz H., Hall-Craggs M.A., et al. The impact of magnetic resonance imaging in determining surgical management in breast cancer. Breast 6 (1997) 177-182 6
6. Veronesi U., Cascinelli N., Mariani M.D., et al. Twenty-year follow-up of a randomised study comparing breast-conserving surgery with radical mastectomy for early breast cancer. NEJM 347 (2002) 1227-1232
7. Veronesi U., Marubini E., Mariani L., et al., Early Breast Cancer Trialist's Collaborative Group. Radiotherapy after breast conserving surgery in small breast carcinoma: long term results of a randomised trial. Ann Oncol 12 (2001) 997-1003
8. Early Breast Cancer Trialist's Collaborative Group. Favourable and unfavourable effects of long-term survival of radiotherapy for early breast cancer; an overview of the randomized trials. Lancet 355 (2000) 1757-1770
9. Foote R.L., Johnson R.E., Donohue J.H., et al. Trends in surgical treatment of breast cancer at Mayo Clinic 1980-2004. Breast 17 (2008) 555-562
10. Surgical guidelines for the management of breast cancer. Association of Breast surgery at BASO. EJSO 35 (2009) S1-S22
11. Keshtgar M.R., and Fukuma E. Endoscopic mastectomy: what does the future hold?. Womens Health 5 2 (2009) 107-109
12. Nicholson R.M., Leinster S., and Sassoon E.M. A comparison of the cosmetic and psychological outcome of breast reconstruction, breast conserving surgery and mastectomy without reconstruction. Breast 16 (2007) 396-410
13. Price J.M., and Rosenberg E.S. The silicone gel breast implant controversy: the rise of expert panels and the fall of junk science. JR Soc Med 93 (2000) 31-34
14. Isern A.E., Loman N., Malina, et al. Histopathological findings and follow-up after prophylactic mastectomy and immediate breast reconstruction in 100 women from families with hereditary breast cancer. EJSO 34 (2008) 1148-1154
15. Morrow M., and Mehrara B. Prophylactic mastectomy and the timing of breast recontruction. Br J Surg 96 (2009) 1-2
16. Tuttle T., Habermann E.B., Grund E.H., Morris T.J., and Virnig B.A. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. JCO 25 (2007) 5203-5209
17. Keshtgar M.R.S., and Ell P.J. Clinical role of sentinel lymph node biopsy in breast cancer. Lancet Oncol 3 2 (2002) 105-110
18. Purushotham A., Upponi S., Klevesath M., Bobrow L., Millar K., Myles J., et al. Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial. J Clin Oncol 23 19 (2005) 4312-4321
19. Mansel R., Fallowfield L., Kissin M., Goyal A., Newcombe R., Dixon J., et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial. J Natl Cancer Inst 98 9 (2006) 599-609
20. Del Bianco P., Zavagno G., Burelli P., Scalco G., Barutta L., Carraro P., et al. Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial. Eur J Surg Oncol 34 5 (2008) 508-513
21. Krag D., Anderson S., Julian T., Brown A., Harlow S., Ashikaga T., et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 Randomised phase III trial. Lancet Oncol 8 10 (2007) 881-888
22. Gill G., and The SNAC Trial Group of the Royal Australasian College of Surgeons (RACS) and NHMRC Clinical Trials Centre. Sentinel-lymph-node-based management or routine axillary clearance? one-year outcomes of sentinel node biopsy versus axillary clearance (SNAC): a randomized controlled surgical trial. Ann Surg Oncol 16 (2009) 266-275
23. Gauthier T., Mollard J., Fermeaux V., et al. Axillary recurrence after negative sentinel lymph node biopsy under local anaesthesia in breast cancer. EJSO 35 (2009) 464-468
24. Blumenkrantz P., Deck K.B., Whitworth P.W., Rosemberg A.L., Reintgen D.S., et al. Clinical evaluation of a molecular assay for the detection of metastases in breast sentinel lymph nodes. Arch Pathol Lab Med 130 (2006) 1397
25. MacNeill F. NEW START: the UK SLNB training programme - a progress report. Bull Royal Coll Surgeons Engl 89 2 (2007) 60-61
26. Viale G., Dell'Orto P., Biasi M.O., et al. Comparative evaluation of an extensive histopathologic examination and a real-time reverse-transcription-polymerase chain reaction assay for mammaglobin and cytokeratin 19 on axillary sentinel lymph nodes of breast carcinoma patients. Ann Surg 247 1 (2008) 136-142
27. Merajver S.D., and Sabel M.S. Inflammatory breast cancer. In: Harris J.R., Lippman M.E., Morrow M., and Osborne C.K. (Eds). Diseases of the breast. 3rd ed. (2004), Lippincott, Williams & Wilkins 971-982
28. Schnitt S.J., and Guidi A.J. Pathology of invasive breast cancer. In: Harris J.R., Lippman M.E., Morrow M., and Osborne C.K. (Eds). Diseases of the breast. 3rd ed. (2004), Lippincott, Williams & Wilkins 541-585
29. Foulkes W.D., Stefansson I.M., Chappuis P.O., Begin L.R., Goffin J.R., Wong N., et al. Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst 95 (2003) 1482-1485
30. Reis-Filho J.S., Milanezi F., Steele D., Savage K., Simpson P.T., Nesland J.M., et al. Metaplastic breast carcinomas are basal-like tumours. Histopathology 49 (2006) 10-21
31. Korkaya H., Paulson A., Iovino F., and Wicha M.S. HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion. Oncogene 27 (2008) 6120-6130 10.1038/onc.2008.207 published online 30 June 2008
32. Kakarala M., and Wicha M.S. Implications of the cancer stem-cell hypothesis for breast cancer prevention and therapy. J Clin Oncol vol 26 17 (2008) 2813-2820 (June 10), 2008